Comparison of Corticosteroid Regimens for COVID-19 and Non-COVID-19 ARDS
Authors:
- Ryosuke ImaiRIRyosuke Imai
- Takayuki NiitsuTNTakayuki Niitsu
- Monica Yun LiuMLMonica Yun Liu
- Hilary FaustHFHilary Faust
- Lynn M. SchnappLSLynn M. Schnapp
- Shota YamamotoSYShota Yamamoto
Open Access
- 2 September 2025
- journal article
- Published by Elsevier in CHEST Critical Care
- Vol. 3 (4)
Abstract
No abstract availableFunding Information
- University of Bristol
This publication has 29 references indexed in Scilit:
- Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic CoughChest, 2024
- Association of Incident Delirium With Short-term Mortality in Adults With Critical Illness Receiving Mechanical VentilationJAMA Network Open, 2022
- Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysisIntensive Care Medicine, 2021
- Pharmacological principles guiding prolonged glucocorticoid treatment in ARDSIntensive Care Medicine, 2020
- Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort studyThe Lancet, 2020
- Chronopharmacology of glucocorticoidsAdvanced Drug Delivery Reviews, 2019
- The dark side of the force: Multiplicity issues in network meta‐analysis and how to address themResearch Synthesis Methods, 2019
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesJAMA, 2016
- Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsiesThe Lancet Respiratory Medicine, 2013
- Effects of methyl prednisolone in early ARDSThe Egyptian Journal of Chest Diseases and Tuberculosis, 2013